Po‐Chin Liang

3.4k total citations
112 papers, 1.9k citations indexed

About

Po‐Chin Liang is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Po‐Chin Liang has authored 112 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hepatology, 50 papers in Surgery and 31 papers in Epidemiology. Recurrent topics in Po‐Chin Liang's work include Hepatocellular Carcinoma Treatment and Prognosis (44 papers), Liver Disease Diagnosis and Treatment (23 papers) and Pancreatitis Pathology and Treatment (17 papers). Po‐Chin Liang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (44 papers), Liver Disease Diagnosis and Treatment (23 papers) and Pancreatitis Pathology and Treatment (17 papers). Po‐Chin Liang collaborates with scholars based in Taiwan, United States and South Korea. Po‐Chin Liang's co-authors include Yu‐Ting Chang, Ming‐Chu Chang, Jau‐Min Wong, Shu‐Chen Wei, Yu‐Wen Tien, Tiffany Ting‐Fang Shih, I‐Shiow Jan, Yung‐Chu Chen, Wen‐Yuan Hsieh and Win-Li Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Po‐Chin Liang

104 papers receiving 1.9k citations

Peers

Po‐Chin Liang
Takaki Sakurai Japan
Pramod Rao France
Hee Chul Yu South Korea
Paolo Dionigi Italy
Lambros Tselikas France
Qing Lü China
Tatsuya Higashi Japan
Kazushi Kishi Japan
Rafael Durán Switzerland
Takaki Sakurai Japan
Po‐Chin Liang
Citations per year, relative to Po‐Chin Liang Po‐Chin Liang (= 1×) peers Takaki Sakurai

Countries citing papers authored by Po‐Chin Liang

Since Specialization
Citations

This map shows the geographic impact of Po‐Chin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Chin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Chin Liang more than expected).

Fields of papers citing papers by Po‐Chin Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐Chin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Chin Liang. The network helps show where Po‐Chin Liang may publish in the future.

Co-authorship network of co-authors of Po‐Chin Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐Chin Liang. A scholar is included among the top collaborators of Po‐Chin Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐Chin Liang. Po‐Chin Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Ja‐Der, Po‐Chin Liang, Chia‐Tung Shun, et al.. (2025). In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 12. 1191–1204.
2.
Too, Chow Wei, Po‐Chin Liang, Chanisa Chotipanich, et al.. (2025). Real-world outcomes of selective internal radiation therapy with 90 Y resin microspheres in HCC/mCRC: RESIN registry Asia. Future Oncology. 21(18). 2287–2297.
3.
Wu, Ming‐Shun, Wei‐Yu Kao, Shih–Jer Hsu, et al.. (2025). Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation. Liver Cancer. 15(1). 149–164.
4.
5.
Lee, Rheun‐Chuan, Po‐Chin Liang, Yi‐Sheng Liu, et al.. (2023). Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment. Frontiers in Oncology. 13. 1186674–1186674.
6.
7.
Hsu, Yuan‐Hung, et al.. (2023). IOP Injection, A Novel Superparamagnetic Iron Oxide Particle MRI Contrast Agent for the Detection of Hepatocellular Carcinoma: A Phase II Clinical Trial. Journal of Magnetic Resonance Imaging. 58(4). 1177–1188. 15 indexed citations
8.
Ma, Weili, Dwan‐Ying Chang, Ching‐Hung Lin, et al.. (2022). Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices. The Oncologist. 27(12). 1008–1015. 2 indexed citations
9.
Huang, Chun‐Chieh, Chao‐Hung Hung, Po‐Chin Liang, et al.. (2018). Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment. Liver Cancer. 7(4). 312–322. 13 indexed citations
10.
Liang, Po‐Chin, Kai‐Wen Huang, Chien‐Chih Tung, et al.. (2017). A novel photodynamic therapy-based drug delivery system layered on a stent for treating cholangiocarcinoma. Biomedical Microdevices. 20(1). 3–3. 4 indexed citations
11.
Chen, Bang‐Bin, Chao‐Yu Hsu, Chih‐Wei Yu, et al.. (2016). Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma. European Radiology. 27(7). 3069–3079. 17 indexed citations
12.
13.
Chang, Ming‐Chu, I‐Shiow Jan, Po‐Chin Liang, et al.. (2015). Cystic fibrosis transmembrane conductance regulator gene variants are associated with autoimmune pancreatitis and slow response to steroid treatment. Journal of Cystic Fibrosis. 14(5). 661–667. 7 indexed citations
14.
Chang, Ming‐Chu, Po‐Chin Liang, I‐Shiow Jan, et al.. (2014). Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort. BMJ Open. 4(8). e005900–e005900. 4 indexed citations
15.
16.
Liang, Po‐Chin, et al.. (2008). The yin–yang sign. Kidney International. 75(1). 128–128. 3 indexed citations
17.
Liang, Po‐Chin, et al.. (2007). Cervical Abscess with Vaginal Fistula After Extraperitoneal Cesarean Section. Journal of the Formosan Medical Association. 106(12). 1048–1051. 4 indexed citations
18.
Liu, Chen‐Hua, Feng‐Chiao Tsai, Po‐Chin Liang, Cha‐Ze Lee, & Pei–Ming Yang. (2006). Splenic vein thrombosis and Klebsiella pneumoniae septicemia after endoscopic gastric variceal obturation therapy with N-butyl-2-cyanoacrylate. Gastrointestinal Endoscopy. 63(2). 336–338. 20 indexed citations
19.
Sheu, Tony W. H., et al.. (2005). Three-dimensional analysis for radio-frequency ablation of liver tumor with blood perfusion effect. Computer Methods in Biomechanics & Biomedical Engineering. 8(4). 229–240. 20 indexed citations
20.
Liu, Kao‐Lang, Po‐Chin Liang, & Yuk‐Ming Tsang. (2001). Angiographic Diagnosis of High-Flow Priapism with Superselective Transcatheter Embolization and Hematofibrinolytic Therapy. 26(4). 169–172. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takaki Sakurai Breakdown of academic impact, for papers by Pramod Rao Breakdown of academic impact, for papers by Hee Chul Yu Breakdown of academic impact, for papers by Paolo Dionigi Breakdown of academic impact, for papers by Lambros Tselikas Breakdown of academic impact, for papers by Qing Lü Breakdown of academic impact, for papers by Tatsuya Higashi Breakdown of academic impact, for papers by Kazushi Kishi Breakdown of academic impact, for papers by Rafael Durán
Rankless by CCL
2026